Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 137.85 EUR -0.25% Market Closed
Market Cap: 59.9B EUR
Have any thoughts about
Merck KGaA?
Write Note

Merck KGaA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merck KGaA
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Merck KGaA
XETRA:MRK
Interest Income Expense
-€74m
CAGR 3-Years
34%
CAGR 5-Years
28%
CAGR 10-Years
10%
ATAI Life Sciences NV
NASDAQ:ATAI
Interest Income Expense
-$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Interest Income Expense
-€2.2B
CAGR 3-Years
-33%
CAGR 5-Years
-6%
CAGR 10-Years
-12%
MPH Health Care AG
XETRA:93M1
Interest Income Expense
€31.5m
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Interest Income Expense
-€64.3m
CAGR 3-Years
-99%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Interest Income Expense
-€2.7m
CAGR 3-Years
-203%
CAGR 5-Years
-221%
CAGR 10-Years
N/A
No Stocks Found

Merck KGaA
Glance View

Market Cap
59.9B EUR
Industry
Pharmaceuticals

In the heart of Darmstadt, Germany, Merck KGaA stands as a testament to innovation and resilience, tracing its roots back to 1668. A bastion of scientific advancement and a pioneer in the world of chemistry and pharmaceuticals, Merck has evolved through centuries of discovery and transformation. Originally a humble pharmacy, Merck has grown into a global powerhouse with a unique structure, being one of the oldest pharmaceutical and chemical companies in the world still owned by the founding family. Though its path has been influenced by numerous historical events, Merck has adeptly navigated the shifting sands of time, transforming itself into a multifaceted conglomerate that thrives on its dual strategy—life sciences and performance materials. In the modern age, Merck KGaA operates through three well-defined sectors: Healthcare, Life Science, and Electronics. Its Healthcare division plays a formidable role, developing innovative drugs, with a focus on oncology, neurology, and immunology, providing cutting-edge treatments that improve patient lives globally. Meanwhile, the Life Science arm caters to researchers and scientists, offering an extensive portfolio of lab materials, high-tech tools, and equipment essential for groundbreaking research across various industries. The Electronics division, dedicated to performance materials, supplies high-quality substances crucial for the electronics and automotive industries, including liquid crystals and highly sophisticated semiconductor solutions. Through these divisions, Merck KGaA not only generates substantial revenue but also drives progress by supplying critical products that are indispensable to the modern technological landscape.

MRK Intrinsic Value
147.51 EUR
Undervaluation 7%
Intrinsic Value
Price

See Also

What is Merck KGaA's Interest Income Expense?
Interest Income Expense
-74m EUR

Based on the financial report for Sep 30, 2024, Merck KGaA's Interest Income Expense amounts to -74m EUR.

What is Merck KGaA's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
10%

Over the last year, the Interest Income Expense growth was 62%. The average annual Interest Income Expense growth rates for Merck KGaA have been 34% over the past three years , 28% over the past five years , and 10% over the past ten years .

Back to Top